Substance / Medication

Cinchocaine

Overview

Active Ingredient
dibucaine
RxNorm CUI
3339
Labeler: Pascal Company, Inc.Updated: 2025-12-10T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Precaine is contraindicated in patients with known hypersensitivity to amine or quinoline type anesthetics.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry.
Abdel-Ghani Nour T, Youssef Ahmed F A, Awady Mohamed A · Farmaco · 2005
PMID: 15910814Observational
Systemic allergic dermatitis after patch testing with cinchocaine (dibucaine) and topical corticosteroids.
Alves da Silva Catarina, Paulsen Evy · Contact Dermatitis · 2019
PMID: 30977131Case Report
Systemic allergic contact dermatitis associated with topical diltiazem and/or cinchocaine.
Santiago L, Moura A L, Coutinho I et al. · J Eur Acad Dermatol Venereol · 2018
PMID: 29423962Case Report
Maculopapular rash of unsuspected cause: systemic contact dermatitis to cinchocaine.
Matos Diogo, Serrano Pedro, Brandão Francisco Menezes · Cutan Ocul Toxicol · 2015
PMID: 25198408Case Report
Allergic contact dermatitis caused by cinchocaine.
González Mahave I, Lobera T, Blasco A et al. · Contact Dermatitis · 2008
PMID: 18154564Case Report
Allergic contact dermatitis to cinchocaine.
Kearney C R, Fewings J · Australas J Dermatol · 2001
PMID: 11309035Case Report
Systemic contact dermatitis from cinchocaine.
Erdmann S M, Sachs B, Merk H F · Contact Dermatitis · 2001
PMID: 11336015Case Report
A synchronous fluorescence spectrofluorometric method for the simultaneous determination of policresulen and cinchocaine hydrochloride in ointment and suppositories.
Salem Hesham, Abdelaziz Amany, Atef Arwa et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2021
PMID: 33744839Other
Simultaneous Determination of Cinchocaine Hydrochloride and Betamethasone Valerate in Presence of Their Degradation Products.
Fayed Ahmed S, Rezk Mamdouh R, Marzouk Hoda M et al. · J Chromatogr Sci · 2017
PMID: 28168304Other
Rapid determination of cinchocaine in skin by high-performance liquid chromatography.
Elsayed Mustafa M A · Biomed Chromatogr · 2007
PMID: 17294504Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cinchocaine (substance)
SNOMED CT
395953008
UMLS CUI
C0012050
RxNorm CUI
3339
Labeler
Pascal Company, Inc.

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.